National Health Investors Inc. Files Definitive Proxy Statement

Ticker: NHI · Form: DEF 14A · Filed: Apr 4, 2024 · CIK: 877860

Sentiment: neutral

Topics: DEF 14A, Proxy Statement, National Health Investors, Executive Compensation, Equity Awards

TL;DR

<b>National Health Investors Inc. has filed its Definitive Proxy Statement for the period ending May 22, 2024, detailing executive compensation and equity awards.</b>

AI Summary

NATIONAL HEALTH INVESTORS INC (NHI) filed a Proxy Statement (DEF 14A) with the SEC on April 4, 2024. National Health Investors Inc. filed a Definitive Proxy Statement (DEF 14A) on April 4, 2024. The filing covers the period ending May 22, 2024. The company's fiscal year ends on December 31. NHI is incorporated in Maryland (MD). The filing includes details on equity awards granted and vested for PEO and Non-PEO members in 2023.

Why It Matters

For investors and stakeholders tracking NATIONAL HEALTH INVESTORS INC, this filing contains several important signals. This filing provides shareholders with crucial information regarding the company's governance, executive compensation structure, and voting matters ahead of shareholder meetings. Understanding the details of equity awards and compensation is vital for shareholders to assess management's alignment with company performance and long-term value creation.

Risk Assessment

Risk Level: low — NATIONAL HEALTH INVESTORS INC shows low risk based on this filing. The filing is a routine DEF 14A, indicating standard disclosure practices rather than immediate material events.

Analyst Insight

Shareholders should review the executive compensation and equity award details to understand management incentives and potential dilution.

Key Numbers

Key Players & Entities

FAQ

When did NATIONAL HEALTH INVESTORS INC file this DEF 14A?

NATIONAL HEALTH INVESTORS INC filed this Proxy Statement (DEF 14A) with the SEC on April 4, 2024.

What is a DEF 14A filing?

A DEF 14A is a definitive proxy statement sent to shareholders before annual meetings, covering executive compensation, board nominations, and shareholder votes. This particular DEF 14A was filed by NATIONAL HEALTH INVESTORS INC (NHI).

Where can I read the original DEF 14A filing from NATIONAL HEALTH INVESTORS INC?

You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by NATIONAL HEALTH INVESTORS INC.

What are the key takeaways from NATIONAL HEALTH INVESTORS INC's DEF 14A?

NATIONAL HEALTH INVESTORS INC filed this DEF 14A on April 4, 2024. Key takeaways: National Health Investors Inc. filed a Definitive Proxy Statement (DEF 14A) on April 4, 2024.. The filing covers the period ending May 22, 2024.. The company's fiscal year ends on December 31..

Is NATIONAL HEALTH INVESTORS INC a risky investment based on this filing?

Based on this DEF 14A, NATIONAL HEALTH INVESTORS INC presents a relatively low-risk profile. The filing is a routine DEF 14A, indicating standard disclosure practices rather than immediate material events.

What should investors do after reading NATIONAL HEALTH INVESTORS INC's DEF 14A?

Shareholders should review the executive compensation and equity award details to understand management incentives and potential dilution. The overall sentiment from this filing is neutral.

How does NATIONAL HEALTH INVESTORS INC compare to its industry peers?

National Health Investors Inc. operates as a real estate investment trust (REIT) focused on healthcare properties.

Are there regulatory concerns for NATIONAL HEALTH INVESTORS INC?

The filing is made under Schedule 14A of the Securities Exchange Act of 1934, which governs the solicitation of proxies.

Industry Context

National Health Investors Inc. operates as a real estate investment trust (REIT) focused on healthcare properties.

Regulatory Implications

The filing is made under Schedule 14A of the Securities Exchange Act of 1934, which governs the solicitation of proxies.

What Investors Should Do

  1. Review the detailed breakdown of equity awards granted and vested for PEO and Non-PEO members in 2023.
  2. Examine any disclosures related to shareholder proposals or voting matters.
  3. Note the company's fiscal year-end and reporting periods for context on financial disclosures.

Year-Over-Year Comparison

This is a DEF 14A filing, which is a standard disclosure document for proxy solicitations and does not inherently represent a change from previous filings of the same type.

Filing Stats: 4,631 words · 19 min read · ~15 pages · Grade level 10.8 · Accepted 2024-04-04 16:08:49

Key Financial Figures

Filing Documents

Executive Compensation

Executive Compensation 22 Equity Ownership Requirements 23 Clawback Policy 24 Role of Compensation Committee 24 Tax and Accounting Considerations 24 202 3 Compensation Tables 26 Potential Payments upon Termination or Change-in-Control 28 Pay Ratio Disclosure 29 Pay Versus Performance Disclosure 30 Equity Compensation Plan Information 34 Independent Registered Public Accounting Firm Fees and Services 35 Compensation Committee Interlocks and Insider Participation 36 Certain Relationships and Related Party Transactions 36 National HealthCare Corporation 36 Pinnacle Financial Partners 37 Policy Regarding Related Party Transactions 37 Beneficial Ownership 37 Proposal 2 Advisory Vote on Compensation of our Named Executive Officers 38 Proposal 3 Ratification of Selection of Independent Registered Public Accounting Firm 39 Voting and Meeting Information 40 Stockholder Communications 43 Additional Information 43 How We Count the Votes 44 Householding 44 Appendix A - Reconciliation of Non-GAAP Financial Measures 45 Proxy Statement PROXY SUMMARY This summary highlights information contained elsewhere in this proxy statement. This summary does not contain all of the information you should consider. Please carefully read the entire proxy statement before voting. Meeting Details The accompanying proxy is solicited by the Board of Directors (the "Board") of National Health Investors, Inc. ("NHI" or the "Company") to be voted at the 2024 Annual Meeting of Stockholders (the "Meeting") to be held on Wednesday, May 22, 2024, commencing at 1:00 p.m. CDT and at any continuance or postponement of the Meeting. The Meeting will be held both virtually and in person (a "hybrid meeting"). Stockholders and guests desiring to attend the Meeting in person, can attend at The View at Fountains, 1500 Medical Center Parkway, Suite 1D, Murfreesboro, Tennessee 37129. Stockholders desiring to attend virtually can log in

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on Read The Filing